{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:34:57Z","timestamp":1792715697920,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024YFFK0172"],"award-info":[{"award-number":["2024YFFK0172"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872959"],"award-info":[{"award-number":["81872959"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jconrel.2026.114654","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:01:15Z","timestamp":1769101275000},"page":"114654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Self-assembled multicomponent prodrugs with GSH\/ROS site-responsiveness enable spatiotemporally controlled release for treating resistant NSCLC"],"prefix":"10.1016","volume":"391","author":[{"given":"Chaozheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114654_bb0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JCO.22.02121","article-title":"Therapy for Stage IV non\u2013small-cell lung cancer without driver alterations: ASCO living guideline, version 2022.2","volume":"41","author":"Owen","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114654_bb0010","first-page":"107","article-title":"Research progress on lipid metabolism in non-small cell lung cancer","volume":"51","author":"Chang","year":"2020","journal-title":"J. China Pharm. Univ."},{"key":"10.1016\/j.jconrel.2026.114654_bb0015","doi-asserted-by":"crossref","first-page":"101223","DOI":"10.1016\/j.drup.2025.101223","article-title":"Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies","volume":"81","author":"Beretta","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2026.114654_bb0020","article-title":"Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor","volume":"26","author":"Zhu","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.114654_bb0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10495-022-01750-z","article-title":"Mechanisms of cancer cell death induction by paclitaxel: an updated review","volume":"27","author":"Zhao","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.jconrel.2026.114654_bb0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc.2017.84","article-title":"Understanding and targeting resistance mechanisms in NSCLC","volume":"17","author":"Rotow","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114654_bb0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41401-023-01219-y","article-title":"Targeted inhibition of the HNF1A\/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.114654_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13073-025-01488-8","article-title":"DNA repair and the contribution to chemotherapy resistance","volume":"17","author":"Nesic","year":"2025","journal-title":"Genome Med."},{"key":"10.1016\/j.jconrel.2026.114654_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101287","article-title":"Targeting DNA damage response pathways in tumor drug resistance: mechanisms, clinical implications, and future directions","volume":"83","author":"Zhu","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2026.114654_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114654_bb0055","doi-asserted-by":"crossref","first-page":"2501420","DOI":"10.1002\/advs.202501420","article-title":"Responsive ROS-augmented prodrug hybridization nanoassemblies for multidimensionally Synergitic treatment of hepatocellular carcinoma in Cascade assaults","volume":"12","author":"Zeng","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114654_bb0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.15212\/AMM-2023-0038","article-title":"Advances in nanoscale carrier-based approaches to reduce toxicity and enhance efficacy of podophyllotoxin","volume":"2","author":"Zhang","year":"2023","journal-title":"Acta Materia Medica"},{"key":"10.1016\/j.jconrel.2026.114654_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156859","article-title":"Voacamine initiates the PI3K\/mTOR\/Beclin1 pathway to induce autophagy and potentiate apoptosis in acute myeloid leukemia","volume":"143","author":"Cao","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2026.114654_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102794","article-title":"Proton pump inhibitors and cancer treatments: emerging evidence against coadministration","volume":"129","author":"Raoul","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2026.114654_bb0075","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ejmech.2018.12.035","article-title":"Small molecule-drug conjugates: a novel strategy for cancer-targeted treatment","volume":"163","author":"Zhuang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114654_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113699","article-title":"Engineering stable prodrug self-assemblies by introducing the bromination effect","volume":"382","author":"Wang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114654_bb0085","first-page":"571","article-title":"Ultrasound-activated carrier-free nanoprodrugs enhanced universality and efficiency of solid tumor-targeting chemotherapy","volume":"50","author":"Xu","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114654_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1725","article-title":"Trisulfide bond\u2013mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity","volume":"6","author":"Yang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114654_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13046-024-03133-5","article-title":"Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer","volume":"43","author":"Chen","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114654_bb0100","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/acs.bioconjchem.5c00145","article-title":"GSH-responsive heterodimeric dual-targeted nanomedicine modulates EMT to conquer paclitaxel-induced invasive breast cancer metastasis","volume":"36","author":"Chen","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.114654_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117153","article-title":"Hydroxyl-based acid-hypersensitive acetal ester bond: design, synthesis and the application potential in nanodrugs","volume":"283","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114654_bb0110","article-title":"Dual targeting of FR+CD44 overexpressing tumors by self-assembled nanoparticles quantitatively conjugating folic acid-hyaluronic acid to the GSH-sensitively modified podophyllotoxin","volume":"505","author":"Zhang","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.114654_bb0115","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1200\/JCO.18.02050","article-title":"Moving from poly (ADP-ribose) polymerase inhibition to targeting DNA repair and DNA damage response in cancer therapy","volume":"37","author":"Gourley","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114654_bb0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12943-025-02355-1","article-title":"Clinical approaches to overcome PARP inhibitor resistance","volume":"24","author":"Zou","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114654_bb0125","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/s41467-025-57257-z","article-title":"PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer","volume":"16","author":"Ran","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114654_bb0130","first-page":"525","article-title":"Research progress of PARP inhibitors in cancers and their drug resistance","volume":"53","author":"Wanwan","year":"2022","journal-title":"J. China Pharm. Univ."},{"key":"10.1016\/j.jconrel.2026.114654_bb0135","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.1021\/acs.jmedchem.3c00922","article-title":"Ligustrazine-derived chalcones-modified platinum (IV) complexes intervene in cisplatin resistance in pancreatic cancer through ferroptosis and apoptosis","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114654_bb0140","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1021\/acs.jmedchem.7b01096","article-title":"Novel ligustrazine-based analogs of piperlongumine potently suppress proliferation and metastasis of colorectal cancer cells in vitro and in vivo","volume":"61","author":"Zou","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114654_bb0145","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3892\/ol.2013.1403","article-title":"Role of the ROS\/AMPK signaling pathway in tetramethylpyrazine-induced apoptosis in gastric cancer cells","volume":"6","author":"Yi","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2026.114654_bb0150","first-page":"2029","article-title":"Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis","volume":"40","author":"Zheng","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2026.114654_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.170036","article-title":"Aptamer-engineered multivalent camptothecin conjugates synergistically orchestrate immunosuppressive microenvironment and DNA damage cascades in colorectal carcinoma","volume":"525","author":"Zuo","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.114654_bb0160","article-title":"Co-delivery of precisely prescribed multi-prodrug combination by an engineered Nanocarrier enables efficient individualized cancer chemotherapy","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114654_bb0165","first-page":"137","article-title":"STAT3-specific nanocarrier for shRNA\/drug dual delivery and tumor synergistic therapy","volume":"41","author":"Sun","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114654_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-019-1112-1","article-title":"The PI3K subunits, P110\u03b1 and P110\u03b2 are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114654_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.70096","article-title":"Melatonin overcomes cancer multidrug resistance by downregulating ABCB1 expression and modulating mitochondrial function","volume":"77","author":"L\u00f3pez-Rodr\u00edguez","year":"2025","journal-title":"J. Pineal Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:40:05Z","timestamp":1781772005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"alternative-id":["S0168365926000556"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114654","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled multicomponent prodrugs with GSH\/ROS site-responsiveness enable spatiotemporally controlled release for treating resistant NSCLC","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114654"}}